Evidence map›Paper›PMID 28058641›Full record

ArticleNanoscale research letters2017

Comparative Analysis of the Antineoplastic Activity of C

O V Lynchak, Yu I Prylutskyy, V K Rybalchenko, O A Kyzyma, D Soloviov, V V Kostjukov, M P Evstigneev, U Ritter, P Scharff

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nanoscale research letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 32 citations in OpenAlex.

  1. CScientific reports · 2021
    Article
  2. Article
  3. Effects of Pristine CDigestive diseases and sciences · 2020
    Article
  4. Synthesis of CACS omega · 2019
    Article
  5. A Novel Nanoconjugate of Landomycin A with CCellular and molecular bioengineering · 2019
    Article
  6. Water-soluble pristine CBioImpacts : BI · 2019
    Article
  7. Effect of CInternational journal of obesity (2005) · 2018
    Article
  8. CCancer nanotechnology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

O V LynchakTaras Shevchenko National University of Kyiv, 64 Volodymyrska Str, 01601, Kyiv, Ukraine. o.lynchak@gmail.com.
Yu I PrylutskyyTaras Shevchenko National University of Kyiv, 64 Volodymyrska Str, 01601, Kyiv, Ukraine.
V K RybalchenkoTaras Shevchenko National University of Kyiv, 64 Volodymyrska Str, 01601, Kyiv, Ukraine.
O A KyzymaTaras Shevchenko National University of Kyiv, 64 Volodymyrska Str, 01601, Kyiv, Ukraine.
D SoloviovJoint Institute for Nuclear Research, Dubna, Moscow Region, Russia.
V V KostjukovSevastopol State University, Sevastopol, Crimea, Ukraine.
M P EvstigneevSevastopol State University, Sevastopol, Crimea, Ukraine.
U RitterInstitute of Chemistry and Biotechnology, Technical University of Ilmenau, 25 Weimarer Str, 98693, Ilmenau, Germany.
P ScharffInstitute of Chemistry and Biotechnology, Technical University of Ilmenau, 25 Weimarer Str, 98693, Ilmenau, Germany.
Taras Shevchenko National University of Kyiv · UAJoint Institute for Nuclear Research · RUTechnische Universität Ilmenau · DEBelgorod National Research University · RUSevastopol National Technical University · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The antitumor activity of pristine C

Indexed as

5-FluorouracilC60 fullereneColorectal cancerMolecular modelingPyrrole derivativeSmall-angle X-ray scattering

Identifiers

PMID28058641
PMCPMC5215998
OpenAlexW2568653294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.